These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23894309)

  • 1. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.
    Jakobsen TH; Hansen MA; Jensen PØ; Hansen L; Riber L; Cockburn A; Kolpen M; Rønne Hansen C; Ridderberg W; Eickhardt S; Hansen M; Kerpedjiev P; Alhede M; Qvortrup K; Burmølle M; Moser C; Kühl M; Ciofu O; Givskov M; Sørensen SJ; Høiby N; Bjarnsholt T
    PLoS One; 2013; 8(7):e68484. PubMed ID: 23894309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.
    Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.
    Traglia G; Papalia M; Almuzara M; Gutkind G; Centrón D; Vay C; Radice M; Ramírez MS
    Curr Microbiol; 2014 Oct; 69(4):501-6. PubMed ID: 24894902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A putative enoyl-CoA hydratase contributes to biofilm formation and the antibiotic tolerance of
    Cameron LC; Bonis B; Phan CQ; Kent LA; Lee AK; Hunter RC
    NPJ Biofilms Microbiomes; 2019; 5(1):20. PubMed ID: 31396394
    [No Abstract]   [Full Text] [Related]  

  • 5. The
    Pickrum AM; Riegert MO; Wells C; Brockman K; Frank DW
    Microbiol Spectr; 2022 Aug; 10(4):e0208322. PubMed ID: 35856670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.
    Bador J; Amoureux L; Blanc E; Neuwirth C
    Antimicrob Agents Chemother; 2013 Jan; 57(1):603-5. PubMed ID: 23089757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Phage Therapy against Pandrug-Resistant
    Lebeaux D; Merabishvili M; Caudron E; Lannoy D; Van Simaey L; Duyvejonck H; Guillemain R; Thumerelle C; Podglajen I; Compain F; Kassis N; Mainardi JL; Wittmann J; Rohde C; Pirnay JP; Dufour N; Vermeulen S; Gansemans Y; Van Nieuwerburgh F; Vaneechoutte M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Insights into Achromobacter mucicolens
    Al-Asadi SA; Al-Kahachi RES; Alwattar WMA; Bootwala J; Sabbah MA
    Microbiol Spectr; 2022 Apr; 10(2):e0191621. PubMed ID: 35377213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.
    Fleurbaaij F; Henneman AA; Corver J; Knetsch CW; Smits WK; Nauta ST; Giera M; Dragan I; Kumar N; Lawley TD; Verhoeven A; van Leeuwen HC; Kuijper EJ; Hensbergen PJ
    Sci Rep; 2018 May; 8(1):8181. PubMed ID: 29802257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characterization of
    Veschetti L; Sandri A; Patuzzo C; Melotti P; Malerba G; Lleo MM
    Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34292148
    [No Abstract]   [Full Text] [Related]  

  • 13. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.
    Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M
    Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla
    Zhu Z; Xu J; He F
    J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
    Mathy V; Grohs P; Compain F
    J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 17. First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.
    Bador J; Amoureux L; Duez JM; Drabowicz A; Siebor E; Llanes C; Neuwirth C
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4912-4. PubMed ID: 21807978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JMM Profile:
    Bonis BM; Hunter RC
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35587447
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete genome sequence of the aromatic-hydrocarbon-degrading bacterium Achromobacter xylosoxidans DN002.
    Li Y; Tian Y; Hao Z; Ma Y
    Arch Microbiol; 2020 Dec; 202(10):2849-2853. PubMed ID: 32683476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.
    Yamamoto M; Nagao M; Hotta G; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    J Antimicrob Chemother; 2012 Sep; 67(9):2110-3. PubMed ID: 22577105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.